Skip to content

TEsting for Arterial Disease in Diabetes (TrEAD) Study

Comparative Diagnostic Accuracy Study of Bedside Tests Used to Detect Arterial Disease in Diabetes:

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04058626
Enrollment
305
Registered
2019-08-15
Start date
2019-03-04
Completion date
2019-10-18
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia, Critical Lower Limb Ischemia, Diabetic Foot, Diabetic Foot Ulcer, Peripheral Arterial Disease, Peripheral Artery Disease, Peripheral Vascular Diseases

Keywords

Peripheral Vascular Diseases, Diabetic Foot, Critical Limb Ischemia, Diagnosis, Peripheral arterial disease, Diabetic foot ulcer, Duplex ultrasound, Ultrasound

Brief summary

This study will focus on determining; * How accurate the test is in detecting poor circulation * How it's accuracy compares to other commonly used tests, and * Whether test results are linked to the chance of ulcer healing or amputation. Across 2 hospitals, 305 diabetic patients will be scanned using the focused ultrasound test as well as other commonly used tests to detect poor circulation. Their results will be compared to a full version of the ultrasound test to identify the most accurate.

Detailed description

In the UK, over 7,000 amputations are performed each year because of diabetes. Most of these (80%) occur when a foot wound, also known as an ulcer, does not heal. The most important cause of this is poor circulation to the feet. Currently, there are no accurate tests that foot specialists can use to detect poor circulation when they see patients. Because of this, poor circulation can be missed and its treatment delayed. A focused ultrasound test at the ankle, using a sensor and gel on the skin, can detect poor circulation. It is safe, painless and I have previously proven that it can be learned and performed quickly. It may help avoid amputations by detecting poor circulation so that it can be treated quickly.

Interventions

DIAGNOSTIC_TESTTranscutaneous pressure of oxygen (TcPO2)

Measurements will be taken from the dorsum of the foot using an automated machine equipped with Clark electrodes.

TBPI will be measured using the photoplethysmography (PPG) method, employing an infrared sensor placed on the hallux and index finger.

Podiatry ankle duplex scan (PAD-scan) involves using an ultrasound machine to visualise the anterior and posterior tibial arteries at the ankle.

DIAGNOSTIC_TESTDuplex Assist

Continuous Doppler device which gives visual display of arterial spectral waveform at the ankle.

A sphygmomanometer-cuff placed at the ankle and a handheld continuous wave Doppler device will be used to measure the systolic pressure of the DPA and PTA.

Sponsors

Imperial College Healthcare NHS Trust
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All diabetic patients presenting to the diabetic foot clinics will be eligible for the study.

Exclusion criteria

* Patients unable to provide informed consent will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Accuracy1 hour; all tests will be performed on the same day of presentation.Diagnostic accuracy of the PAD-scan and other bedside tests will be compared to the results of a full lower limb Duplex Ultrasound scan (reference test).

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Study Participants
Participants with diabetes were consecutively enrolled into the study across 2 centers.
305
Total305

Baseline characteristics

CharacteristicStudy Participants
Active ulceration123 Participants
Age, Continuous72 years
Neuropathy203 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
99 Participants
Sex: Female, Male
Male
206 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 305
other
Total, other adverse events
0 / 305
serious
Total, serious adverse events
0 / 305

Outcome results

Primary

Diagnostic Accuracy

Diagnostic accuracy of the PAD-scan and other bedside tests will be compared to the results of a full lower limb Duplex Ultrasound scan (reference test).

Time frame: 1 hour; all tests will be performed on the same day of presentation.

Population: Missing data were observed in 7 (2.3%) patients for ABPI, 71 (23.3%) patients for TBPI and 16 (5.2%) patients for TcPO2.

ArmMeasureGroupValue (NUMBER)
Study ParticipantsDiagnostic AccuracyPAD-scan sensitivity95 Percent
Study ParticipantsDiagnostic AccuracyPAD-scan specificity77 Percent
Study ParticipantsDiagnostic AccuracyTBPI specificity86 Percent
Study ParticipantsDiagnostic AccuracyPulse sensitivity43 Percent
Study ParticipantsDiagnostic AccuracyPulse specificity81 Percent
Study ParticipantsDiagnostic AccuracyDoppler (audible) sensitivity74 Percent
Study ParticipantsDiagnostic AccuracyDoppler (audible) specificity76 Percent
Study ParticipantsDiagnostic AccuracyDoppler (visual) sensitivity83 Percent
Study ParticipantsDiagnostic AccuracyDoppler (visual) specificity75 Percent
Study ParticipantsDiagnostic AccuracyABPI sensitivity60 Percent
Study ParticipantsDiagnostic AccuracyABPI specificity75 Percent
Study ParticipantsDiagnostic AccuracyTcPO2 sensitivity31 Percent
Study ParticipantsDiagnostic AccuracyTcPO2 specificity79 Percent
Study ParticipantsDiagnostic AccuracyTBPI sensitivity60 Percent

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026